Scholarlink

<p>Endoplasmic reticulum stress (ERS) dynamically regulates cell fate decisions within the tumor microenvironment (TME) through the PERK, IRE1α, and ATF6 pathways of the unfolded protein response (UPR), forming an “ERS-Death Axis” interconnected with apoptosis, autophagy, pyroptosis, and ferroptosis. Its molecular network involves CHOP-mediated apoptotic imbalance, NLRP3 inflammasome-activated pyroptosis, the ATF4–CHAC1 axis-driven ferroptosis, and the dual roles of autophagy (protective or pro-death). Oxidative stress further amplifies the biological functions of this network. The ERS-Death Axis exhibits significant heterogeneity across different tumors. Therapeutic strategies targeting this axis have demonstrated clear potential, including specific modulation of core UPR molecules, pathway activation by natural compounds, synergistic combinations with immune checkpoint inhibitors and metabolic interventions, and enhanced targeting and efficacy through nanodelivery systems. However, clinical translation faces key challenges such as tumor heterogeneity, drug delivery efficiency, and complex resistance mechanisms. In-depth elucidation of the tumor-specific mechanisms underlying the ERS-Death Axis will provide crucial theoretical support for overcoming bottlenecks in cancer therapy and optimizing combination treatment regimens, propelling this axis to become a core target for precision oncology.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Endoplasmic reticulum stress-mediated programmed cell death in the tumor microenvironment

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月17日

查看全文
  • Hongyu Chai,
  • Qian Hu,
  • Shun Yao,
  • Shuoguo Ma,
  • Wei Su

摘要

Endoplasmic reticulum stress (ERS) dynamically regulates cell fate decisions within the tumor microenvironment (TME) through the PERK, IRE1α, and ATF6 pathways of the unfolded protein response (UPR), forming an “ERS-Death Axis” interconnected with apoptosis, autophagy, pyroptosis, and ferroptosis. Its molecular network involves CHOP-mediated apoptotic imbalance, NLRP3 inflammasome-activated pyroptosis, the ATF4–CHAC1 axis-driven ferroptosis, and the dual roles of autophagy (protective or pro-death). Oxidative stress further amplifies the biological functions of this network. The ERS-Death Axis exhibits significant heterogeneity across different tumors. Therapeutic strategies targeting this axis have demonstrated clear potential, including specific modulation of core UPR molecules, pathway activation by natural compounds, synergistic combinations with immune checkpoint inhibitors and metabolic interventions, and enhanced targeting and efficacy through nanodelivery systems. However, clinical translation faces key challenges such as tumor heterogeneity, drug delivery efficiency, and complex resistance mechanisms. In-depth elucidation of the tumor-specific mechanisms underlying the ERS-Death Axis will provide crucial theoretical support for overcoming bottlenecks in cancer therapy and optimizing combination treatment regimens, propelling this axis to become a core target for precision oncology.